In one paragraphArticle in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Girma MulisaDepartment of Microbiology, Immunology and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-3619-8579 Jingcheng ZhaoDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0009-0004-0447-6652 Geda LelissaDepartment of Internal Medicine, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Iyunoluwa J Ademola-PopoolaDepartment of Anthropology, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0009-0008-9050-9914 Anastacia Marie Diaz HuemmeDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0009-0003-3388-4885 Laura S WeyrichDepartment of Anthropology, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0001-5243-4634 Adane MihretDepartment of Microbiology, Immunology and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia.
Tufa GemechuDepartment of Pathology, School of Medicine College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Abate BaneDepartment of Internal Medicine, School of Medicine College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Roger Pero-GasconCenter of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-5019-1405 Marthe De BoevreCenter of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0002-6151-5126 Sarah De SaegerCenter of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0002-2160-7253 Tamrat Abebe *Department of Microbiology, Immunology and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia.
Jordan E Bisanz *Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0002-8649-1706 Funding
Decoding Microbial Diversity in the Human Gut MicrobiomeR35GM151045 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Jordan Adam Bisanz · 2023 to 2026
$1.5MEuropean Research Council 946192 HUMYCONational Science Foundation DGE1255832NIGMS NIH HHS R35 GM151045Research Foundation Flanders 12D4423N
6 · The paper itselfAbstract
Esophageal cancer (EC) results in high mortality due to difficulty in early diagnosis, particularly in low- and middle-income countries, including the African EC belt typified by high prevalence, early onset, and poor prognosis. While the precise etiological factors remain unknown, emerging data suggest links to the oral microbiota. In this study, we conducted a secondary analysis using V4 16S rRNA sequencing from a cross-sectional study of treatment-naive, newly diagnosed EC patients (
Indexed as
Esophageal NeoplasmsMicrobiotaSalivaAdenocarcinomaAdultAgedCohort StudiesCross-Sectional StudiesEast African PeopleEsophageal Squamous Cell CarcinomaEthiopiaFemaleHumansMaleMiddle AgedPrevalenceRNA, Ribosomal, 16Sesophageal cancermeta-analysismicrobiomesaliva
Identifiers
PMID42227762
PMCPMC13288984
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390